Should Biotechnology Stock Epizyme Inc (EPZM) Be in Your Portfolio Friday?

Friday, November 12, 2021 11:08 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Epizyme Inc (EPZM) Be in Your Portfolio Friday?

Epizyme Inc (EPZM) is near the middle in its industry group according to InvestorsObserver. EPZM gets an overall rating of 37. That means it scores higher than 37 percent of stocks. Epizyme Inc gets a 45 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.

EPZM has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on EPZM!

See Full EPZM Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 37 means the stock is more attractive than 37 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Epizyme Inc Stock Today?

Epizyme Inc (EPZM) stock is down -3.76% while the S&P 500 is up 0.24% as of 11:08 AM on Friday, Nov 12. EPZM has fallen -$0.17 from the previous closing price of $4.66 on volume of 200,611 shares. Over the past year the S&P 500 is up 31.76% while EPZM has fallen -60.02%. EPZM lost -$2.62 per share the over the last 12 months. Click Here to get the full Stock Report for Epizyme Inc stock.